GH1 and diabetes mellitus: Recent expert consensus recommends surveillance of hemoglobin A1c, fasting glucose, and fasting insulin for those receiving hGH therapy and consideration of an oral glucose tolerance test (OGTT) for those who are obese, and/or >12 years old, and/or have a family history of diabetes [23].